Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study

Autor: Ulrik Schiøler Kesmodel, kamilla karlsen, Ole Mogensen, Peter Humaidan, Pernille Ravn

Publikováno v: BMJ Open, Vol 10, Iss 2 (2020)

ObjectiveThe aim was to investigate the association between clinically significant uterine fibroids and preterm birth, caesarean section (CS), postpartum haemorrhage (PPH), placental abruption, intrauterine growth restriction (IUGR) and uterine ruptu

Externí odkaz: https://doaj.org/article/3d3b8b4a158843e08110395885fbd287

First child’s impact on parental relationship: an existential perspective

Autor: Christina Prinds, Ole Mogensen, Niels Christian Hvidt, Mette Bliddal

Publikováno v: BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-7 (2018)

Abstract Background The first child’s birth is for most mothers a profound experience carrying the potential to change life orientations and values. However, little is known of how becoming a mother influences the existential dimensions of life wit

Externí odkaz: https://doaj.org/article/7d6b799b8270465a9523278d73646f01

The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer

Autor: Sarah Marie Bjørnholt, Sarah Elizabeth Sponholtz, Ole Mogensen, Kirsten Bouchelouche, Erik Thorlund Parner, Gudrun Neumann, Kirsten Marie Jochumsen, Bushra Hassan Hamid, Morten Bülow Davidsen, Signe Frahm Bjørn, Katja Dahl, Pernille Tine Jensen

Publikováno v: Bjørnholt, S M, Sponholtz, S E, Mogensen, O, Bouchelouche, K, Parner, E T, Neumann, G, Jochumsen, K M, Hamid, B H, Davidsen, M B, Bjørn, S F, Dahl, K & Jensen, P T 2023, ' The SENTIREC-endo study-Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer ', Gynecologic Oncology, vol. 171, pp. 121-128 . https://doi.org/10.1016/j.ygyno.2023.02.013

OBJECTIVE: The SENTIREC-endo study aims to investigate risks and benefits of a national protocolled adoption of sentinel lymph node (SLN) mapping in women with early-stage low-grade endometrial cancer (EC) with low- (LR) and intermediate-risk (IR) of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6d2b7aaf909e73c6476f1c79861cde
https://pure.au.dk/portal/da/publications/the-sentirecendo-study--risks-and-benefits-of-a-national-adoption-of-sentinel-node-mapping-in-low-and-intermediate-risk-endometrial-cancer(d012039c-8289-4fcf-97df-61679f6fe5c0).html

SENTIREC - The sentinel node mapping in women with cervical cancer study

Autor: Sara Elisabeth Sponholtz, Nicole P.M. Ezendam, Belle H. de Rooij, Erik Parner, Ole Mogensen, Malene Grubbe Hildebrandt, Doris Schledermann, Algirdas Markauskas, Ligita Paskeviciute Frøding, Katrine Fuglsang, Sarah Marie Bjørnholt, Pernille Tine Jensen

Publikováno v: Sponholtz, S E, Ezendam, N P M, de Rooij, B H, Parner, E, Mogensen, O, Hildebrandt, M G, Schledermann, D, Markauskas, A, Frøding, L P, Fuglsang, K, Bjørnholt, S M & Jensen, P T 2022, ' SENTIREC – The sentinel node mapping in women with cervical cancer study – Patient-reported early lymphedema and its impact on quality of life ', Gynecologic Oncology, vol. 164, no. 3, pp. 463-472 . https://doi.org/10.1016/j.ygyno.2021.12.024
Gynecologic Oncology, 164(3), 463-472. Academic Press Inc.

Objective: To evaluate patient-reported incidence and severity of early lymphedema and its impact on quality of life (QoL) after sentinel lymph node (SLN) mapping only and after SLN and pelvic lymphadenectomy (PL) in women undergoing surgery for earl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514686ef023e0b140f4e8947415e878d
https://doi.org/10.1016/j.ygyno.2021.12.024

Sentinel lymph node mapping in early-stage cervical cancer – A national prospective multicenter study (SENTIREC trial)

Autor: Erik T. Parner, Katrine Fuglsang, Sarah Marie Bjørnholt, Mie Holm Vilstrup, Pernille Tine Jensen, Doris Schledermann, Sara Elisabeth Sponholtz, Algirdas Markauskas, Ole Mogensen, Ligita Paskeviciute Frøding, Malene Hildebrandt

Publikováno v: Sponholtz, S E, Mogensen, O, Hildebrandt, M G, Schledermann, D, Parner, E, Markauskas, A, Frøding, L P, Fuglsang, K, Vilstrup, M H, Bjørnholt, S M & Jensen, P T 2021, ' Sentinel lymph node mapping in early-stage cervical cancer-A national prospective multicenter study (SENTIREC trial) ', Gynecologic Oncology, vol. 162, no. 3, pp. 546-554 . https://doi.org/10.1016/j.ygyno.2021.06.018
Sponholtz, S E, Mogensen, O, Hildebrandt, M G, Schledermann, D E, Parner, E, Markauskas, A, Frøding, L, Fuglsang, K, Vilstrup, M H, Bjørnholt, S & Jensen, P 2021, ' Sentinel lymph node mapping in early-stage cervical cancer – a national prospective multicenter study (sentirec trial) ', International Journal of Gynecological Cancer, vol. 31, no. Suppl. 4, A11 . https://doi.org/10.1136/ijgc-2021-igcs.18
Sponholtz, S E, Mogensen, O, Hildebrandt, M G, Schledermann, D, Parner, E, Markauskas, A, Frøding, L P, Fuglsang, K, Vilstrup, M H, Bjørnholt, S M & Jensen, P T 2021, ' Sentinel lymph node mapping in early-stage cervical cancer – A national prospective multicenter study (SENTIREC trial) ', Gynecologic Oncology, vol. 162, no. 3, pp. 546-554 . https://doi.org/10.1016/j.ygyno.2021.06.018

OBJECTIVES: Sentinel lymph node (SLN) mapping may replace staging radical pelvic lymphadenectomy in women with early-stage cervical cancer. In a national multicenter setting, we evaluated SLN mapping in women with early-stage cervical cancer and inve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf16c63c41c43162cc53263528beb97
https://doi.org/10.1016/j.ygyno.2021.06.018